| High T-cell immune activation and immune exhaustion among individuals with suboptimal CD4 recovery after 4 years of antiretroviral therapy in an African cohort D Nakanjako, I Ssewanyana, H Mayanja-Kizza, A Kiragga, ... BMC infectious diseases 11, 1-9, 2011 | 147 | 2011 |
| Atorvastatin reduces T‐cell activation and exhaustion among HIV‐infected c ART‐treated suboptimal immune responders in U ganda: a randomised crossover placebo‐controlled trial D Nakanjako, I Ssinabulya, R Nabatanzi, L Bayigga, A Kiragga, M Joloba, ... Tropical medicine & international health 20 (3), 380-390, 2015 | 60 | 2015 |
| Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells R Nabatanzi, S Cose, M Joloba, SR Jones, D Nakanjako AIDS research and therapy 15, 1-8, 2018 | 58 | 2018 |
| Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort R Nabatanzi, L Bayigga, S Cose, S Rowland-Jones, G Canderan, ... Clinical Immunology 201, 55-60, 2019 | 43 | 2019 |
| Monocyte dysfunction, activation, and inflammation after long-term antiretroviral therapy in an African cohort R Nabatanzi, L Bayigga, S Cose, S Rowland Jones, M Joloba, ... The Journal of infectious diseases 220 (9), 1414-1419, 2019 | 29 | 2019 |
| Bronchoalveolar lavage enzyme-linked immunospot for diagnosis of smear-negative tuberculosis in HIV-infected patients A Cattamanchi, I Ssewenyana, R Nabatanzi, CR Miller, S Den Boon, ... PLoS One 7 (6), e39838, 2012 | 28 | 2012 |
| High CD56++CD16- natural killer (NK) cells among suboptimal immune responders after four years of suppressive antiretroviral therapy in an African adult HIV … L Bayigga, R Nabatanzi, PN Sekiziyivu, H Mayanja-Kizza, MR Kamya, ... BMC immunology 15, 1-8, 2014 | 23 | 2014 |
| Impaired T-cell proliferation among HAART-treated adults with suboptimal CD4 recovery in an African cohort D Nakanjako, I Ssewanyana, R Nabatanzi, A Kiragga, MR Kamya, H Cao, ... BMC immunology 14, 1-9, 2013 | 22 | 2013 |
| Low antigen-specific CD4 T-cell immune responses despite normal absolute CD4 counts after long-term antiretroviral therapy an African cohort R Nabatanzi, L Bayigga, I Ssinabulya, A Kiragga, A Kambugu, J Olobo, ... Immunology letters 162 (2), 264-272, 2014 | 18 | 2014 |
| Type 2 diabetes mellitus and latent tuberculosis infection moderately influence innate lymphoid cell immune responses in Uganda P Ssekamatte, M Nakibuule, R Nabatanzi, M Egesa, C Musubika, ... Frontiers in immunology 12, 716819, 2021 | 14 | 2021 |
| CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda D Nakanjako, J Otiti-Sengeri, I Ssewanyana, R Nabatanzi, L Bayigga, ... Immunology letters 161 (1), 44-49, 2014 | 14 | 2014 |
| Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda E Seremba, P Ocama, R Ssekitoleko, H Mayanja-Kizza, SV Adams, ... Vaccine 39 (8), 1265-1271, 2021 | 12 | 2021 |
| Diverse vaginal microbiome was associated with pro-inflammatory vaginal milieu among pregnant women in Uganda L Bayigga, R Nabatanzi, A Ssekagiri, DP Kateete, M Sekikubo, ... Human Microbiome Journal 18, 100076, 2020 | 11 | 2020 |
| Innate lymphoid cell dysfunction during long-term suppressive antiretroviral therapy in an African cohort R Nabatanzi, L Bayigga, S Cose, G Canderan, S Rowland Jones, ... BMC immunology 22 (1), 59, 2021 | 9 | 2021 |
| Translational research in Uganda: linking basic science to bedside medicine in a resource limited setting R Kwizera, E Mande, D Omali, S Okurut, S Nabweyambo, R Nabatanzi, ... Journal of translational medicine 19, 1-6, 2021 | 8 | 2021 |
| Therapeutic immunization in HIV infected Ugandans receiving stable antiretroviral treatment: a Phase I safety study C Kityo, S Bousheri, J Akao, F Ssali, R Byaruhanga, I Ssewanyana, ... Vaccine 29 (8), 1617-1623, 2011 | 8 | 2011 |
| Longitudinal Changes in CD4+, CD8+ T Cell Phenotype and Activation Marker Expression Following Antiretroviral Therapy Initiation among Patients with … A Bayiyana, S Okurut, R Nabatanzi, G Zziwa, DR Boulware, F Lutwama, ... Journal of Fungi 5 (3), 63, 2019 | 5 | 2019 |
| Increased Levels of Caspase-1 and IL-1β Among Adults With Persistent Immune Activation After 12 Years of Suppressive Antiretroviral Therapy in the Infectious Diseases Institute … R Nabatanzi, P Ssekamatte, B Castelnuovo, A Kambugu, D Nakanjako Open Forum Infectious Diseases 10 (11), ofad539, 2023 | 3 | 2023 |
| Variations in Trim5α and Cyclophilin A genes among HIV-1 elite controllers and non controllers in Uganda: a laboratory-based cross-sectional study SB Amanya, B Nyiro, F Waswa, B Obura, R Nakaziba, E Nabulime, ... Retrovirology 17, 1-11, 2020 | 3 | 2020 |
| Assessment of the immunomodulatory activity of Artavol aqueous extract in Plasmodium berghei infected mice M Amanya, CO Ajayi, B Natukunda, F Wasswa, A Bayiyana, R Nabatanzi, ... African Journal of Pharmacy and Pharmacology 16 (5), 79-89, 2022 | 2 | 2022 |
Nakanjako DamalieProfessor of Medicine, Makerere University College of Health Sciences在 idi.co.ug 的电子邮件经过验证
